Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Average Ratings 0 Ratings

Total
ease
features
design
support

No User Reviews. Be the first to provide a review:

Write a Review

Description

Organizations in the life sciences sector, regardless of their size or complexity, depend on the ICyte platform to enhance pharmaceutical market entry and therapy commercialization processes. The ICyte platform equips biotech and pharmaceutical manufacturers with exceptional services that include the aggregation of channel and patient data, management of contracts and pricing, gross-to-net forecasting, and accrual systems, as well as expert solutions for launch and pricing transparency. By utilizing ICyte, both pharmaceutical and biotech firms can significantly enhance their market access capabilities by swiftly converting patient, payer, complex transaction, and channel data into practical insights. Additionally, ICyte offers analytics-as-a-service, facilitating the deployment of standardized models and metrics as a unified service across various applications, data streams, and analytical uses. The platform integrates key performance indicators (KPIs) tailored specifically for life sciences organizations. Furthermore, it features advanced analytics tools, including forecasting, scenario modeling, and a recommendation engine powered by machine learning, which aid companies in making data-driven decisions. Ultimately, ICyte is positioned as a comprehensive solution that not only simplifies processes but also empowers organizations to navigate the complexities of the pharmaceutical landscape effectively.

Description

The Veradigm Real-World Evidence (RWE) analytics platform is an economical software-as-a-service solution designed for the clear and efficient analysis of real-world data. This platform is utilized by organizations in life sciences and clinical research to delve into electronic health records (EHR) data comprehensively. Adhering to OMOP standards, the analytical platform enhances the efficiency and reliability of generating real-world evidence. By leveraging the Veradigm Network data, users can execute population analyses in mere minutes, build reusable patient cohorts with consistent terminology across various data sources, and facilitate repeatable retrospective studies. Additionally, the platform supports analysis on any dataset that fits within the Observational Medical Outcomes Partnership (OMOP) Common Data Model (CDM), including those sourced from Veradigm Network EHR Data. Overall, this powerful tool is designed to streamline research processes and enhance the quality of insights derived from real-world data.

API Access

Has API

API Access

Has API

Screenshots View All

Screenshots View All

Integrations

No details available.

Integrations

No details available.

Pricing Details

No price information available.
Free Trial
Free Version

Pricing Details

No price information available.
Free Trial
Free Version

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Deployment

Web-Based
On-Premises
iPhone App
iPad App
Android App
Windows
Mac
Linux
Chromebook

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Customer Support

Business Hours
Live Rep (24/7)
Online Support

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Types of Training

Training Docs
Webinars
Live Training (Online)
In Person

Vendor Details

Company Name

IntegriChain

Founded

2005

Country

United States

Website

www.integrichain.com/products/icyte-platform/

Vendor Details

Company Name

Veradigm

Country

United States

Website

veradigm.com/evalytica-real-world-evidence-analytics/

Product Features

Product Features

Alternatives

Alternatives